Approach to the Patient with Gas and Bloating

Principles of Clinical Gastroenterology

Volumn , Issue , 2009, Pages 255-270

  Hasler, William L ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

Eructation or belching; Evaluation of patient with gas and bloating; Gas production; Gas transit; Gastrointestinal tract contains less than 200 mL gas; Pathogenesis of gas and bloating; Principles of management prokinetic medications

Indexed keywords

EID: 84886085304     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781444300758.ch15     Document Type: Chapter

References (178)

1. Tomlin J, Lowis C, Read NW. Investigation of normal flatus production in healthy volunteers. Gut 1991;32:665.
2. Furne JK, Levitt MD. Factors influencing frequency of flatus emission by healthy subjects. Dig Dis Sci 1996;41:1631.
3. Suarez F, Furne J, Springfield J, Levitt M. Insights into human colonic physiology obtained from the study of flatus composition. Am J Physiol 1997;272:G1028.
4. Suarez FL, Springfield J, Levitt MD. Identification of gases responsible for the odour of human flatus and evaluation of a device purported to reduce this odour. Gut 1998;43:100.
5. Bolin TD, Stanton RA. Flatus emission patterns and fibre intake. Eur J Surg Suppl 1998;582:115.
6. Strocchi A, Levitt MD. Factors affecting hydrogen production and consumption by human fecal flora. The critical roles of hydrogen tension and methanogenesis. J Clin Invest 1992;89:1304.
7. Hertzler SR, Savaiano DA, Levitt MD. Fecal hydrogen production and consumption measurements. Response to daily lactose ingestion by lactose maldigesters. Dig Dis Sci 1997;42:348.
8. Serra J, Azpiroz F, Malagelada JR. Intestinal gas dynamics and tolerance in humans. Gastroenterology 1998;115:542.
9. Gonlachanvit S, Coleski R, Owyang C, Hasler WL. Inhibitory actions of a high fibre diet on intestinal gas transit in healthy humans. Gut 2004;53:1577.
10. Gonlachanvit S, Coleski R, Owyang C, Hasler WL. Nutrient modulation of intestinal gas dynamics in healthy humans: dependence on caloric content and meal consistency. Am J Physiol-Gastrointest Liver Physiol 2006;291:G389.
11. Serra J, Azpiroz F, Malagelada JR. Gastric distention and duodenal lipid perfusion modulate intestinal gas transit and tolerance in humans. Am J Gastroenterol 2002;97:2225.
12. Hernando-Harder AC, Serra J, Azpiroz F, Malagelada JR. Sites of symptomatic gas retention during intestinal lipid perfusion in healthy subjects. Gut 2004;53:661.
13. Dianese R, Serra J, Azpiroz F, Malagelada JR. Influence of body posture on intestinal transit of gas. Gut 2003;52:971.
14. Dianese R, Serra J, Azpiroz F, Malagelada JR. Effects of physical activity on intestinal gas transit and evacuation in healthy subjects. Am J Med 2004;116:536.
15. Coleski R, Hasler W. Induction of propagated colonic contractions during jejunal gas perfusion in healthy humans: a possible physiologic enterocolonic reflex for expulsion of excess luminal gas (abstract). Neurogastroenterol Motil 2007;19:423.
16. Tremolaterra F, Villoria A, Serra J, et al. Intestinal tone and gas motion. Neurogastroenterol Motil 2006;18:905.
17. Serra J, Azpiroz F, Malagelada JR. Mechanisms of intestinal gas retention in humans: impaired propulsion versus obstructed evacuation. Am J Physiol-Gastrointest Liver Physiol 2001;281:G138.
18. Harder H, Serra J, Azpiroz F, et al. Intestinal gas distribution determines abdominal symptoms. Gut 2003;52:1708.
19. Harder H, Serra J, Azpiroz F, Malagelada JR. Reflex control of intestinal gas dynamics and tolerance in humans. Am J Physiol-Gastrointest Liver Physiol 2004;286:G89.
20. Kahrilas PJ, Dodds WJ, Dent J, et al. Upper esophageal sphincter function during belching. Gastroenterology 1986;91:133.
21. Bassotti G, Germani U, Morelli A. Flatus-related colorectal and anal motor events. Dig Dis Sci 1996;41:335.
22. Sandler RS, Stewart WF, Liberman JN, et al. Abdominal pain, bloating, and diarrhea in the United States-prevalence and impact. Dig Dis Sci 2000;45:1166.
23. Drossman DA, Li Z, Andruzzi E, et al. US householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact. Dig Dis Sci 1993;38:1569.
24. Scrimshaw NS, Murray EB. The acceptability of milk and milk products in populations with a high prevalence of lactose intolerance. Am J Clin Nutr 1988;48(4 Suppl.):1079.
25. Suarez FL, Savaiano DA, Levitt MD. A comparison of symptoms after the consumption of milk or lactose-hydrolyzed milk by people with self-reported severe lactose intolerance. N Engl J Med 1995; 333:1.
26. 2. measurements). J Lab Clin Med 1975;85:546.
27. Ravich WJ, Bayless TM, Thomas M. Fructose: incomplete absorption in humans. Gastroenterology 1983;84:26.
28. Jain NK, Rosenberg DB, Ulahannan MJ, et al. Sorbitol intolerance in adults. Am J Gastroenterol 1985;80:678.
29. Hyams JS. Sorbitol intolerance: an unappreciated cause of functional gastrointestinal complaints. Gastroenterology 1983;84:30.
30. Lee A, Zumbe A, Storey D. Breath hydrogen after ingestion of the bulk sweeteners sorbitol, isomalt and sucrose in chocolate. Br J Nutr 1994;71:731.
31. Bond JH, Currier BE, Buchwald H, Levitt MD. Colonic conservation of malabsorbed carbohydrate. Gastroenterology 1980;78:444.
32. Ouwendijk J, Moolenaar CE, Peters WJ, et al. Congenital sucrase-isomaltase deficiency: identification of a glutamine to praline substitution that leads to a transport block of sucrase-isomaltase in a pre-Golgi compartment. J Clin Invest 1996;97:633.
33. 2 excretion after ingestion of complex carbohydrates. Gastroenterology 1987;92:383.
34. Suarez FL, Springfield J, Furne JK, et al. Gas production in human ingesting a soybean flour derived from beans naturally low in oligosaccharides. Am J Clin Nutr 1999;69:135.
35. 2 and symptom response to ingestion of sorbitol or oat fiber. Am J Gastroenterol 1997;92:89.
36. Levitt MD, Furne J, Olsson S. The relation of passage of gas and abdominal bloating to colonic gas production. Ann Intern Med 1996;124:422.
37. Suau A. Molecular tools to investigate intestinal bacterial communities. J Pediatr Gastroenterol Nutr 2003;3:222.
38. Gorbach SL, Barza M, Giuliano M, Jacobus NV. Colonization resistance of the human intestinal microflora: testing the hypothesis in normal volunteers. Eur J Clin Microbiol Infect Dis 1988;7:98.
39. Gibson GR, Wang X. Regulatory effects of bifidobacteria on the growth of other colonic bacteria. J Appl Bacteriol 1994;77:412.
40. Houghton LA, Green TJ, Donovan UM, et al. Association between dietary fiber intake and the folate status of a group of female adolescents. Am J Clin Nutr 1997;66:1414.
41. Langlands SJ, Hopkins MJ, Coleman N, Cummings JH. Prebiotic carbohydrates modify the mucosa associated microflora of the human large bowel. Gut 2004; 53: 1610-1616.
42. Bauer TM, Steinbruckner B, Brinkmann FE, et al. Small intestinal bacterial overgrowth in patients with cirrhosis: prevalence and relation with spontaneous bacterial peritonitis. Am J Gastroenterol 2001;96:2962.
43. Fried M, Siegrist H, Frei R, et al. Duodenal bacterial overgrowth during treatment in outpatients with omeprazole. Gut 1994;35:23.
44. Virally-Monod M, Tielmans D, Kevorkian JP, et al. Chronic diarrhea and diabetes mellitus: prevalence of small intestinal bacterial overgrowth. Diabetes Metab 1998;24:530.
45. Reddymasu S, Sarosiek I, Sostarich S, McCallum R. Incidence and predictors of small intestinal bacterial overgrowth in gastroparesis (abstract). Gastroenterology 2007;132:686.
46. Lin HC, Van Citters GW, Zhao XT, Waxman A. Fat intolerance depends on rapid gastric emptying. Dig Dis Sci 1999;44:330.
47. Anvari M, Allen C. Postprandial bloating after laparoscopic Nissen fundoplication. Can J Surg 2001;44:440.
48. Lembo T, Naliboff B, Munakata J, et al. Symptoms and visceral perception in patients with pain-predominant irritable bowel syndrome. Am J Gastroenterol 1999;94:1320.
49. Hahn B, Watson M, Yan S, et al. Irritable bowel syndrome patterns: frequency, duration, and severity. Dig Dis Sci 1998;43:2715.
50. Lee OY, Mayer EA, Schmulson M, et al. Gender-related differences in IBS symptoms. Am J Gastroenterol 2001;96:2184.
51. Heitkemper MM, Cain KC, Jarrett ME, et al. Relationship of bloating to other GI and menstrual symptoms in women with irritable bowel syndrome. Dig Dis Sci 2004;49:88.
52. Chang L, Lee OY, Naliboff B, et al. Sensation of bloating and visible abdominal distension in patients with irritable bowel syndrome. Am J Gastroenterol 2001;96:3341.
53. Maxton DG, Whorwell PJ. Abdominal distension in irritable bowel syndrome: the patient's perception. Eur J Gastroenterol Hepatol 1992;4:241.
54. Schmulson M, Lee OY, Chang L, et al. Symptom differences in moderate to severe IBS patients based on predominant bowel habit. Am J Gastroenterol 1999;94:2929.
55. Talley NJ, Dennis EH, Schettler-Duncan VA, et al. Overlapping upper and lower gastrointestinal symptoms in irritable bowel syndrome patients with constipation or diarrhea. Am J Gastroenterol 2003;98:2454.
56. Ragnarsson G, Bodemar G. Division of the irritable bowel syndrome into subgroups on the basis of daily recorded symptoms in two outpatients samples. Scand J Gastroenterol 1999;34:993.
57. Lea R, Reilly B, Whorwell PJ, Houghton LA. The effect of bowel habit and time of day on the relationship between bloating and visible distension in patients with irritable bowel syndrome (abstract). Gastroenterology 2004;126:1634.
58. Azpiroz F, Malagelada JR. Abdominal bloating. Gastroenterology 2005;129:1060.
59. Koide A, Yamaguchi T, Odaka T, et al. Quantitative analysis of bowel gas using plain abdominal radiograph in patients with irritable bowel syndrome. Am J Gastroenterol 2000;95:1735.
60. Chami TN, Schuster MM, Bohlman ME, et al. A simple radiologic method to estimate the quantity of bowel gas. Am J Gastroenterol 1991;86:599.
61. Tolliver BA, Herrera JL, DiPalma JA. Evaluation of patients who meet clinical criteria for irritable bowel syndrome. Am J Gastroenterol 1994;89:176.
62. Tolliver BA, Jackson MS, Jackson KL, et al. Does lactose maldigestion really play a role in the irritable bowel? J Clin Gastroenterol 1996;23:15.
63. Lisker R, Solomons NW, Perez BR, Ramirez MM. Lactase and placebo in the management of the irritable bowel syndrome: a double-blind, cross-over study. Am J Gastroenterol 1989;84:756.
64. Fernandez-Banares F, Esteve-Pardo M, de Lean R, et al. Sugar malabsorption in functional bowel disease: clinical implications. Am J Gastroenterol 1993;88:2044.
65. Goldstein R, Braverman D, Stankiewicz H. Carbohydrate malabsorption and the effect of dietary restriction on symptoms in irritable bowel syndrome and functional bowel complaints. Isr Med Assoc J 2000;2:583.
66. Hotz J, Plein K. Effectiveness of plantago seed husks in comparison with wheat bran on stool frequency and manifestations of irritable colon syndrome with constipation. Med Klin 1994;89:645.
67. Wollner JT, Kirby GA. Clinical audit of the effects of low-fibre diet on irritable bowel syndrome. J Human Nutr Diet 2000;13:249.
68. King TS, Elia M, Hunter DO. Abnormal colonic fermentation in irritable bowel syndrome. Lancet 1998;352:1187.
69. Haderstorfer B, Whitehead WE, Schuster MM. Intestinal gas production from bacterial fermentation of undigested carbohydrate in irritable bowel syndrome. Am J Gastroenterol 1989;84:375.
70. Balsari A, Ceccarelli A, Dubini F, et al. The fecal microbial population in the irritable bowel syndrome. Microbiologica 1982;5:185.
71. Khalif IL, Quigley EM, Konovitch EA, Maximova ID. Alterations in the colonic flora and intestinal permeability and evidence of immune activation in chronic constipation. Dig Liver Dis 2005; 37: 838.
72. Malinen E, Rinttila T, Kajander K, et al. Analysis of the fecal micro-biota of irritable bowel syndrome patients and healthy controls with real-time PCR. Am J Gastroenterol 2005;100:373.
73. Pimentel M, Chow EJ, Lin HC. Eradication of small intestinal bacterial overgrowth reduces symptoms of irritable bowel syndrome. Am J Gastroenterol 2000;95:3503.
74. Pimentel M, Soffer EE, Chow EJ, et al. Lower frequency of MMC is found in IBS subjects with abnormal lactulose breath test, suggesting bacterial overgrowth. Dig Dis Sci 2002;47:2639.
75. Pimentel M, Mayer AG, Park S, et al. Methane production during lactulose breath test is associated with gastrointestinal disease presentation. Dig Dis Sci 2003;48:86.
76. Pimentel M, Lin HC, Enayati P, et al. Methane, a gas produced by enteric bacteria, slows intestinal transit and augments small intestinal contractile activity. Am J Physiol-Gastrointest Liver Physiol 2006;290:G1089.
77. Coleski R, Hasler W. Hydrogen and methane breath testing for small intestinal bacterial overgrowth in patients with unexplained gas and bloating: factors relating to test positivity and response to antibiotics (abstract). Neurogastroenterol Motil 2007;19:433.
78. Pimentel M, Kong Y, Park S. IBS subjects with methane on lactulose breath test have lower postprandial serotonin levels than subjects with hydrogen. Dig Dis Sci 2004;49:84.
79. Walters B, Vanner SJ. Detection of bacterial overgrowth in IBS using the lactulose H2 breath test: comparison with 14C-D-xylose and healthy controls. Am J Gastroenterol 2005;100:1566.
80. Lupascu A, Gabrielli M, Lauritano EC, et al. Hydrogen glucose breath test to detect small intestinal bacterial overgrowth: a prevalence case-control study in irritable bowel syndrome. Aliment Pharmacol Ther 2005;22:1157.
81. 99mTc bran scan. Lancet 1986; 2:364.
82. Lasser RB, Bond JH, Levitt MD. The role of intestinal gas in functional abdominal pain. N Engl J Med 1975;293:524.
83. Serra J, Azpiroz F, Malagelada JR. Impaired transit and tolerance of intestinal gas in the irritable bowel syndrome. Gut 2001;48:14.
84. Salvioli B, Serra J, Azpiroz F, et al. Origin of gas retention and symptoms in patients with bloating. Gastroenterology 2005;128:574.
85. Serra J, Salvioli B, Azpiroz F, Malagelada JR. Lipid-induced intestinal gas retention in irritable bowel syndrome. Gastroenterology 2002;123:700.
86. Salvioli B, Serra J, Azpiroz F, Malagelada JR. Impaired small bowel gas propulsion in patients with bloating during intestinal lipid perfusion. Am J Gastroenterol 2006;101:1853.
87. Passos M, Serra J, Azpiroz F, et al. Impaired reflex control of intestinal gas transit in patients with abdominal bloating. Gut 2005;54:344.
88. Galati JS, McKee DP, Quigley EM. Response to intraluminal gas in irritable bowel syndrome. Motility versus perception. Dig Dis Sci 1995;40:1381.
89. Lea R, Reilly B, Whorwell PJ, Houghton LA. Abdominal bloating in the absence of physical distension is related to increased visceral sensitivity (abstract). Gastroenterology 2004;126:432.
90. Maxton DG, Martin DF, Whorwell PJ, Godfrey M. Abdominal distension in female patients with irritable bowel syndrome: exploration of possible mechanisms. Gut 1991;32:662.
91. Perez F, Accarino AM, Azpiroz F, et al. Measurement of intestinal gas volume using a new CT-based analysis program (abstract). Gastroenterology 2005;128:A675.
92. Lewis MJ, Reilly B, Houghton LA, Whorwell PJ. Ambulatory abdominal inductance plethysmography: towards objective assessment of abdominal distension in irritable bowel syndrome. Gut 2001;48:216.
93. Reilly BP, Bolton MP, Lewis MJ, et al. A device for 24 hour ambulatory monitoring of abdominal girth using inductive plethysmo-graphy. Physiol Meas 2002;23:661.
94. Houghton LA, Lea R, Agrawal A, et al. Relationship of abdominal bloating to distension in irritable bowel syndrome and effect of bowel habit. Gastroenterology 2006;131:1003.
95. McManis PG, Newall D, Talley NJ. Abdominal wall muscle activity in irritable bowel syndrome. Am J Gastroenterol 2001;96:1139.
96. Tremolaterra F, Villoria A, Azpiroz F, et al. Impaired viscerosomatic reflexes and abdominal-wall dystony associated with bloating. Gas-troenterology 2006;130:1062.
97. Sanders DS, Carter MJ, Hurlstone DP, et al. Association of adult coeliac disease with irritable bowel syndrome: a case-control study in patients fulfilling ROME II criteria referred to secondary care. Lancet 2001;358:1504.
98. Zar S, Benson MJ, Kumar D. Serum IgG4 antibodies to common food antigens are elevated in irritable bowel syndrome (abstract). Gut 2002;50(Suppl. 11):A25.
99. El Rafei A, Peters SM, Harris N, Bellanti JA. Diagnostic value of IgG4 measurements in patients with food allergy. Ann Allergy 1989;62:94.
100. Sullivan SN. A prospective study of unexplained visible abdominal bloating. NZ Med J 1994;107:428.
101. 2 in this condition. Gastroenterology 1995;108:1560.
102. Tolliver BA, Berry MA, DiPalma JA. Eructation flambe. J Clin Gastroenterol 1994;18:267.
103. Bond JH, Levitt MD. Factors affecting the concentration of combustible gases in the colon during colonoscopy. Gastroenterology 1976;68:1445.
104. Cash BD, Schoenfeld P, Chey WD. The utility of diagnostic tests in irritable bowel syndrome patients: a systematic review. Am J Gastroenterol 2002;97:2812.
105. Spiegel BM, DeRosa VP, Gralnek IM, et al. Testing for celiac sprue in irritable bowel syndrome with predominant diarrhea: a cost-effectiveness analysis. Gastroenterology 2004;126:1721.
106. Mein SM, Ladabaum U. Serological testing for coeliac disease in patients with symptoms of irritable bowel syndrome: a cost-effectiveness analysis. Aliment Pharmacol Ther 2004;19:1199.
107. Lucchinetti CF, Kimmel DW, Lennon VA. Paraneoplastic and onco-logic profiles of patients seropositive for type 1 antineuronal nuclear autoantibodies. Neurology 1998;50:652.
108. Maglinte DD, Peterson LA, Vahey TN, et al. Enteroclysis in partial small bowel obstruction. Am J Surg 1984;147:325.
109. Strocchi A, Ellis C, Levitt MD. Reproducibility of measurements of trace gas concentrations in expired air. Gastroenterology 1991;101:175.
110. Barr RG, Watkins JB, Perman JA. Mucosal function and breath hydrogen excretion: comparative studies in the clinical evaluation of children with nonspecific abdominal complaints. Pediatrics 1981; 68:526.
111. Hermans MM, Brummer RJ, Ruijgers AM, Stockbrugger RW. The relationship between lactose intolerance test results and symptoms of lactose intolerance. Am J Gastroenterol 1997;92:981.
112. Choi YK, Johlin FC, Summers RW, et al. Fructose intolerance: an under-recognized problem. Am J Gastroenterol 2003;98:1348.
113. 2 criteria. Gastroenterology 1993;105:1404.
114. Corazza GR, Menozzi MG, Strocchi A, et al. The diagnosis of small bowel bacterial overgrowth. Reliability of jejunal culture and inadequacy of breath hydrogen testing. Gastroenterology 1990;98:302.
115. Riordan SM, McIver CJ, Duncombe VM, et al. Evaluation of the rice hydrogen breath test for small intestinal bacterial overgrowth. Am J Gastroenterol 2000;95:2858.
116. Miller MA, Parkman HP, Urbain JL, et al. Comparison of scinti-graphy and lactulose breath hydrogen test for assessment of oro-cecal transit. Lactulose accelerates small bowel transit. Dig Dis Sci 1997;42:10.
117. Charles F, Camilleri M, Phillips SF, et al. Scintigraphy of the whole gut: clinical evaluation of transit disorders. Mayo Clin Proc 1995;70:113.
118. Metcalf AM, Phillips SF, Zinsmeister AR, et al. Simplified assessment of segmental colonic transit. Gastroenterology 1987;92:40.
119. Levitt MD, Furne J, Aeolus MR, Suarez FL. Evaluation of an extremely flatulent patient: case report and proposed diagnostic and therapeutic approach. Am J Gastroenterol 1998;93:2276.
120. Vesa TH, Korpela RA, Sahi T. Tolerance to small amounts of lactose in lactose maldigesters. Am J Clin Nutr 1996;64:197.
121. Kolars JC, Levitt MD, Aouji M, Savaiano DA. Yogurt-an auto-digesting source of lactose. N Engl J Med 1984;310:1.
122. Vesa TH, Marteau P, Zidi S, et al. Digestion and tolerance of lactose from yoghurt and different semi-solid fermented dairy products containing Lactobacillus acidophilus and bifidobacteria in lactose maldigesters-is bacterial lactase important? Eur J Clin Nutr 1996;50:730.
123. Nwinuka NM, Abbey BW, Ayalogu EO. Effect of processing on flatus producing oligosaccharides in cowpea (Vigna unguiculata) and the troipical African yam bean (Sphenostylis stenocarpa). Plant Foods Hum Nutr 1997;51:209.
124. Machaiah JP, Pednekar MD, Thomas P. Reduction in flatulence factors in mung beans (Vigna raidata) using low-dose gammairradiation. J Sci Food Agricult 1999;79:648.
125. Fernandez-Banares F, Rosinach M, Esteve M, et al. Sugar malabsorption in functional abdominal bloating: a pilot study on the long-term effect of dietary treatment. Clin Nutr 2006;25:824.
126. Shepherd SJ, Gibson PR. Fructose malabsorption and symptoms of irritable bowel syndrome: guidelines for effective dietary management. J Am Diet Assoc 2006;106:1631.
127. Levitt MD. Follow-up of a flatulent patient. Dig Dis Sci 1979;24:652.
128. Wahnschaffe U, Ullrich R, Riecken EO, Schulzke JD. Celiac diseaselike abnormalities in a subgroup of patients with irritable bowel syndrome. Gastroenterology 2001;121:1329.
129. Zar S, Mincher M, Benson MJ, Kumar D. Food specific IgG4 antibody guided exclusion diet improves symptoms in irritable bowel syndrome (abstract). Colorect Dis 2002;4(Suppl. 1):P100.
130. Villoria A, Serra J, Azpiroz F, Malagelada JR. Physical activity and intestinal gas clearance in patients with bloating. Am J Gastroenterol 2006;101:2552.
131. Lin MY, DiPalma JA, Martini MC, et al. Comparative effects of exogenous lactase (β-galactosidase) preparations on in vivo lactose digestion. Dig Dis Sci 1993;38:2022.
132. Medow MS, Thek KD, Newman LJ, et al. β-galactosidase tablets in the treatment of lactose intolerance in pediatrics. Am J Dis Child 1990;144:1261.
133. Ramirez FC, Lee K, Graham DY. All lactase preparations are not the same: results of a prospective, randomized, placebo-controlled trial. Am J Gastroenterol 1994;89:566.
134. Ganiats TG, Norcross WA, Halverson AL, et al. Does Beano prevent gas? A double-blind crossover study of oral α-galactosidase to treat dietary oligosaccharide intolerance. J Fam Pract 1994;39:441.
135. Suarez F, Levitt MD, Adshead J, Barkin JS. Pancreatic supplements reduce symptomatic response of healthy subjects to a high fat meal. Dig Dis Sci 1999;44:1317.
136. Treem WR, McAdams L, Stanford L, et al. Sacrosidase therapy for congenital sucrase-isomaltase deficiency. J Ped Gastroenterol Nutr 1999;28:137.
137. Holtmann G, Gschossmann J, Karaus M, et al. Randomised doubleblind comparison of simethicone with cisapride in functional dyspepsia. Aliment Pharmacol Ther 1999;13:1459.
138. Kaplan MA, Prior MJ, Ash RR, et al. Loperamide-simethicone vs. loperamide alone, simethicone alone, and placebo in the treatment of acute diarrhea with gas-related abdominal discomfort. A randomized controlled trial. Arch Fam Med 1999;8:243.
139. Hall RG, Thompson H, Strother A. Effects of orally administered activated charcoal on intestinal gas. Am J Gastroenterol 1981;75:192.
140. Jain NK, Patel VP, Pitchumoni CS. Efficacy of activated charcoal in reducing intestinal gas: a double-blind clinical trial. Am J Gas-troenterol 1986;81:532.
141. Giffard CJ, Collins SB, Stoodley NC, et al. Administration of charcoal, Yucca schidigera, and zinc acetate to reduce malodorous flatulence in dogs. J Am Vet Med Assoc 2001;218:892.
142. Suarez FL, Furne J, Springfield J, Levitt MD. Failure of activated charcoal to reduce the release of gases produced by the colonic flora. Am J Gastroenterol 1999;94:208.
143. Suarez FL, Furne JK, Springfield J, Levitt MD. Bismuth subsalicylate markedly decreases hydrogen sulfide release in the human colon. Gastroenterology 1998;114:923.
144. Kaye SA, Lim SG, Taylor M, et al. Small bowel bacterial overgrowth in systemic sclerosis: detection using direct and indirect methods and treatment outcome. Br J Rheumatol 1995;34:265.
145. Bouhnik Y, Alain S, Attar A, et al. Bacterial populations contaminating the upper gut in patients with small intestinal bacterial overgrowth syndrome. Am J Gastroenterol 1999;94:1327.
146. Attar A, Flourie B, Rambaud JC, et al. Antibiotic efficacy in small intestinal bacterial overgrowth-related chronic diarrhea: a crossover, randomized trial. Gastroenterology 1999;117:794.
147. Dear KL, Elia M, Hunter JO. Do interventions which reduce colonic bacterial fermentation improve symptoms of irritable bowel syndrome? Dig Dis Sci 2005;50:758.
148. Pimentel M, Chow EJ, Lin HC. Normalization of lactulose breath testing correlates with symptom improvement in irritable bowel syndrome. a double-blind, randomized, placebo-controlled study. Am J Gastroenterol 2003;98:412.
149. Pimentel M, Chatterjee S, Chow EJ, et al. Neomycin improves constipation-predominant irritable bowel syndrome in a fashion that is dependent on the presence of methane gas: subanalysis of a doubleblind randomized controlled study. Dig Dis Sci 2006;51:1297.
150. Di Stefano M, Strocchi A, Malservisi S, et al. Non-absorbable antibiotics for managing intestinal gas production and gas-related symptoms. Aliment Pharmacol Ther 2000;14:1001.
151. Sharara AI, Aoun E, Abdul-Baki H, et al. A randomized double-blind placebo-controlled trial of rifaximin in patients with abdominal bloating and flatulence. Am J Gastroenterol 2006;101:326.
152. Pimentel M, Park S, Mirocha J, et al. The effect of a nonabsorbed oral antibiotic (rifaximin) on the symptoms of the irritable bowel syndrome: a randomized trial. Ann Intern Med 2006;145:557.
153. Penner R, Fedorak RN, Madsen KL. Probiotics and nutraceuticals: non-medicinal treatments of gastrointestinal diseases. Curr Opin Pharmacol 2005;5:596.
154. Kim HJ, Camilleri M, McKinzie S, et al. A randomized controlled trial of a probiotic, VSL#3, on gut transit and symptoms in diarrhoea-predominant irritable bowel syndrome. Aliment Pharmacol Ther 2003;17:895.
155. Kim HJ, Vazquez Roque MI, Camilleri M, et al. A randomized controlled trial of a probiotic combination VSL# 3 and placebo in irritable bowel syndrome with bloating. Neurogastroenterol Motil 2005;17:687.
156. Brigidi P, Vitali B, Swennen E, et al. Effects of probiotic administration upon the composition and enzymatic activity of human fecal microbiota in patients with irritable bowel syndrome or functional diarrhea. Res Microbiol 2001;152:735.
157. O'Mahony L, McCarthy J, Kelly P, et al. Lactobacillus and bifidobac-terium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles. Gastroenterology 2005;128:541.
158. Whorwell PJ, Altringer L, Morel J, et al. Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome. Am J Gastroenterol 2006;101:1581.
159. Nobaek S, Johansson ML, Molin G, et al. Alteration of intestinal microflora is associated with reduction in abdominal bloating and pain in patients with irritable bowel syndrome. Am J Gastroenterol 2000;95:1231.
160. Kajander K, Hatakka K, Poussa T, et al. A probiotic mixture alleviates symptoms in irritable bowel syndrome patients: a controlled 6-month intervention. Aliment Pharmacol Ther 2005;22:387.
161. Pimentel M, Constantino T, Kong Y, et al. A 14-day elemental diet is highly effective in normalizing the lactulose breath test. Dig Dis Sci 2004;49:73.
162. Gibson GR, Beatty ER, Wang X, Cummings JH. Selective stimulation of bifidobacteria in the human colon by oligofructose and inulin. Gastroenterology 1995;108:975.
163. Bouhnik Y, Attar A, Joly FA, et al. Lactulose ingestion increases faecal bifidobacterial counts: a randomized double-blind study in healthy humans. Eur J Clin Nutr 2004; 58: 462-466.
164. Bouhnik Y, Raskine L, Simoneau G, et al. The capacity of short-chain fructo-oligosaccharides to stimulate faecal bifidobacteria: a dose-response relationship study in healthy humans. Nutr J 2006;5:8.
165. Langlands SJ, Hopkins MJ, Coleman N, Cummings JH. Prebiotic carbohydrates modify the mucosa associated microflora of the human large bowel. Gut 2004;53:1610.
166. Bittner AC, Croffut RM, Stranahan MC. Prescript-Assist probiotic-prebiotic treatment for irritable bowel syndrome: a methodologically oriented, 2-week, randomized, placebo-controlled, double-blind clinical study. Clin Ther 2005;27:755.
167. 4 receptor partial agonist, relieves symptoms in irritable bowel syndrome patients with abdominal pain, bloating, and constipation. Aliment Pharmacol Ther 2001;15:1655.
168. Bardhan KD, Forbes A, Marsden CL, et al. The effects of withdrawing tegaserod treatment in comparison with continuous treatment in irritable bowel syndrome patients with abdominal pain/discomfort, bloating and constipation: a clinical study. Aliment Pharmacol Ther 2004;20:213.
169. 4 receptor agonist tegaserod. Am J Gastroenterol 2006;101:1858.
170. Caldarella MP, Serra J, Azpiroz F, Malagelada JR. Prokinetic effects in patients with intestinal gas retention. Gastroenterology 2002;122:1748.
171. Tack J, Broekaert D, Fischler B, et al. A controlled crossover study of the selective serotonin reuptake inhibitor citalopram in irritable bowel syndrome. Gut 2006;55:1095.
172. Vahedi H, Merat S, Rashidioon A, et al. The effect of fluoxetine in patients with pain and constipation-predominant irritable bowel syndrome: a double-blind randomized-controlled study. Aliment Pharmacol Ther 2005;22:381.
173. Tabas G, Beaves M, Wang J, et al. Paroxetine to treat irritable bowel syndrome no responding to high-fiber diet: a double-blind, placebo-controlled trial. Am J Gastroenterol 2004;99:915.
174. Vej dani R, Shalmani HR, Mir-Fattahi M, et al. The efficacy of an herbal medicine, Carmint, on the relief of abdominal pain and bloating in patients with irritable bowel syndrome: a pilot study. Dig Dis Sci 2006;51:1501.
175. Gonsalkorale WM, Houghton LA, Whorwell PJ. Hypnotherapy in irritable bowel syndrome: a large-scale audit of a clinical service with examination of factors influencing responsiveness. Am J Gas-troenterol 2002;97:954.
176. Palsson OS, Turner MJ, Johnson DA, et al. Hypnosis treatment for severe irritable bowel syndrome: investigation of mechanism and effects on symptoms. Dig Dis Sci 2002;47:2605.
177. Moulis H, Vender RJ. Percutaneous endoscopic gastrostomy for treatment of gas-bloat syndrome. Gastrointest Endosc 1993;39:581.
178. Murr MM, Sarr MG, Camilleri M. The surgeon's role in the treatment of chronic intestinal pseudoobstruction. Am J Gastroenterol 1995; 90: 2147.